Befejeződött1. fázis
A first-in-human study to determine the safety and tolerability of different doses of GEH200520 Injection and GEH200521 (18F) Injection and their uses in positron emission tomography imaging for patients with cancer
Key facts
- Where
- Amsterdam és Groningen, HollandiaSee the 2 sites
- Phase
- 1. fázis
Where in Hollandia
- Stichting Amsterdam UMCAmsterdam, HollandiaNo longer taking part
- Universitair Medisch Centrum GroningenGroningen, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- GE Healthcare Limited
- Trial code
- EU 2024-515218-42-00
- Record updated
- 2026. június 5.